Lagercrantz acquires Schmitztechnik GmbH

Vinge has advised Lagercrantz Group in connection with the acquisition of the German company Schmitztechnik GmbH, which is a market leader in several OEM segments with customer specific silicon, rubber, PUR and industrial plastic products with Germany as its largest market.

Pulsen Production acquires Borås based IT company Make IT

Advokatfirman Vinge has advised Pulsen Production AB in conjunction with the acquisition of the Borås based IT company Make IT i Borås AB from XXIT i Borås AB. 

Vinge has assisted Max Sievert in acquisition of Nordic Traction Group

Vinge has advised AB Max Sievert in connection with its acquisition of Nordic Traction Group AB and subsidiaries.

Vinge has advised CGNEE Sweden Holding AB in connection with the acquisition of North Pole Vindkraft Holding AB

Vinge has advised CGNEE Sweden Holding AB in connection with the acquisition of North Pole Vindkraft Holding AB from Green Investment Group Limited and GE Capital Global Energy Investment B.V.

Vinge is advising Dole Food Company, Inc

Vinge is advising Dole Food Company, Inc., in connection with the sale of all of the shares in Saba Fresh Cuts AB and Saba Fresh Cuts Oy to BAMA International AS.

Vinge is advising Danica Pension, Livsforsikringsaktieselskab, part of Danske Bank Group, in connection with the sale of all of shares in Danske Pension Försäkringsaktiebolag (publ).

Danica Pension Försäkringsaktiebolag (publ) has approx. 60 employees, 150,000 personal customers and 15,000 business customers.

Vinge has advised 10x Genomics, Inc in connection with the acquisition of Spatial Transcriptomics

Spatial Transcriptomics is active within the field of spatial genomics.

Vinge advises Azelio in connection with its capital raising and listing on Nasdaq First North

Vinge has advised Azelio AB (publ) (“Azelio”) in connection with its capital raising and listing on Nasdaq First North.

Vinge advises Xspray Pharma in connection with a directed share issue

The board of directors of Xspray Pharma AB (publ) has resolved on a directed new issue of shares, whereby Xspray Pharma will raise proceeds of approximately SEK 92 million, before issue costs. 

Vinge advises in connection with the sale of school operations

Vinge has advised the sellers in connection with the sale of Kubikskolan AB to Læringsverkstedet.

Vinge advises Biotage in connection with its acquisition of PhyNexus

Vinge advises Biotage AB (publ) (“Biotage”), listed on Nasdaq Stockholm, in connection with its acquisition of PhyNexus, Inc. (“PhyNexus”), financed through a combination of newly issued shares and existing cash at hand.

Vinge assists Stendörren in connection with EQT Real Estate II’s cash offer to the shareholders in Stendörren

Vinge has assisted Stendörren Fastigheter AB (publ) (“Stendörren”) in connection with EQT Real Estate II’s, through Chicago Holding AB (“Chicago Holding”), cash offer to the shareholders in Stendörren.

Vinge advises Vicore Pharma in connection with a directed share issue

The board of directors of Vicore Pharma has resolved, subject to the approval by an extraordinary general meeting, on a directed new issue of shares, whereby Vicore Pharma will raise proceeds of approximately SEK 160 million before issue costs. 

Vinge has advised Aprea Therapeutics in connection with its EUR 50 million financing

Aprea Therapeutics AB, with headquarters in Stockholm (Solna), is a biotechnology company focused on the discovery and development of new cancer drugs reactivating the tumour suppressor protein p53. 

Vinge has advised Swedish Airport Infrastructure in connection with a restructuring

Vinge has advised Swedavia Real Estate AB’s and Alecta pensionsförsäkring ömsesidigt’s jointly-owned joint venture company Swedish Airport Infrastructure KB and its subsidiary in connection with a restructuring of the group and a SEK 3.7 billion refinancing.